---
title: "STAT+: Forbion raises $2.6 billion, its largest fundraise to date"
description: "Forbion, a prominent European venture capital firm, said it has raised $2.6 billion, its largest fundraise to date and one of the largest in the region in recent years."
author: "Elaine Chen"
section: health
published: 2026-10-24T13:30:04.277958+00:00
canonical: https://valorandventures.media/article/246b5f2e-328d-4522-810d-63394f1a9be8
publisher: "Valor & Ventures Media"
source: "STAT News"
source_url: https://www.statnews.com/2026/10/07/biotech-news-forbion-raises-2-6-billion-largest-fundraise/?utm_campaign=rss
access: free
---

# STAT+: Forbion raises $2.6 billion, its largest fundraise to date

*Forbion, a prominent European venture capital firm, said it has raised $2.6 billion, its largest fundraise to date and one of the largest in the region in recent years.*

## Executive Summary

European venture capital firm Forbion has secured $2.6 billion in fresh commitments, establishing the largest capital raise in the organization's history, according to reporting from STAT News. The closing represents one of the most substantial venture funding packages completed across Europe in recent years, positioning the firm with an unprecedented reservoir of investment resources. As reported by STAT News correspondent Elaine Chen, the multi-billion-dollar haul reflects notable momentum within the life sciences and venture ecosystem. In an environment where private equity and venture markets have faced headwinds and cautious institutional allocations, Forbion's ability to complete a record-setting transaction indicates that institutional investors remain willing to commit substantial capital to specialized investment managers with established operational focus. The scale of the capital pool provides the firm with significant latitude to deploy capital across its strategic mandates. While broader market conditions have prompted many allocators to pull back, securing $2.6 billion equips the manager with substantial dry powder to anchor early-stage initiatives and finance later-stage development paths. For sectors requiring intensive research and development, multi-billion-dollar fund sizes allow general partners to back portfolio companies across prolonged execution timelines without relying entirely on volatile external syndications. From a macroeconomic perspective, the transaction highlights the continuing maturation and institutional appeal of the European venture landscape. Historically, mega-funds of this magnitude have been disproportionately concentrated among North American venture firms. The realization of one of the continent's largest fundraises in recent memory demonstrates that European capital managers can command major global commitments and maintain parity in funding scale with international peers. For entrepreneurs, executives, and leaders tracking the capital markets, Forbion's record fundraise offers an informative signal regarding the availability of long-horizon capital. The successful closing illustrates that despite disciplined market adjustments, high-conviction sectors continue to command substantial liquidity when supported by experienced stewardship. For emerging innovators and business builders, the presence of major institutional reserves reinforces that high-quality, research-driven enterprises retain access to the funding necessary to execute complex strategic visions.

## Article

---
Elaine Chen · STAT News · Photo: Adobe

---

Originally published by STAT News: https://www.statnews.com/2026/10/07/biotech-news-forbion-raises-2-6-billion-largest-fundraise/?utm_campaign=rss